Kawaguchi Yoshikuni, Fuks David, Nomi Takeo, Levard Hughes, Gayet Brice
Department of Digestive Diseases, Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Department of Digestive Diseases, Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France; Institut des Systèmes Intelligents et Robotique (ISIR), Université Pierre et Marie Curie, Paris, France.
Surgery. 2015 Jun;157(6):1106-12. doi: 10.1016/j.surg.2014.12.015. Epub 2015 Feb 20.
Although laparoscopic distal pancreatectomy (LDP) has increasingly gained popularity, there are only a few reports mentioning application and outcomes of LDP for adenocarcinoma of the body and tail of the pancreas. The aim of our study is to demonstrate technical details of LDP employing radical en bloc procedure (en bloc LDP) and to evaluate the short- and long-term outcomes of en bloc LDP applied for adenocarcinoma.
We evaluated 23 consecutive patients who underwent LDP for adenocarcinoma in the body or tail of the pancreas. Our concepts of en bloc LDP for adenocarcinoma comprise 3 principles: en bloc removal of retroperitoneal structures, lymph node (LN) dissection, and preservation of the spleen.
En bloc LDP without splenectomy was performed in 17 patients (74%) and en bloc LDP with splenectomy was in 6 patients (26%). Mean ± standard deviation operation time was 203 ± 54 minutes, and mean estimated blood loss was 208 ± 264 mL. Conversion to open distal pancreatectomy was required in 1 patient (4%) owing to the severe adhesions around the pancreas. The overall morbidity rate following en bloc LDP was 47% (n = 11), and the rate of pancreatic fistula was 39% (n = 9). There were no 30-day or in-hospital mortalities. Mean tumor size was 32 ± 12 mm, and mean number of harvested LNs was 19.8 ± 9.3. No patient had positive margins on final histologic diagnosis. The 1-, 3-, and 5-year overall survival rates were 67%, 49%, and 33%, respectively.
En bloc LDP can be applied safely by the surgeon with advanced experience in minimally invasive surgery with satisfactory short- and long-term outcomes, supporting further application of LDP for adenocarcinoma with advances in operative techniques and technological innovations.
尽管腹腔镜远端胰腺切除术(LDP)越来越受欢迎,但仅有少数报告提及LDP用于胰腺体尾部腺癌的应用及结果。我们研究的目的是展示采用根治性整块切除手术(整块切除LDP)的LDP技术细节,并评估整块切除LDP用于腺癌的短期和长期结果。
我们评估了23例连续接受LDP治疗胰腺体尾部腺癌的患者。我们对于腺癌的整块切除LDP概念包括3项原则:整块切除腹膜后结构、淋巴结(LN)清扫以及保留脾脏。
17例患者(74%)接受了未行脾切除的整块切除LDP,6例患者(26%)接受了行脾切除的整块切除LDP。平均±标准差手术时间为203±54分钟,平均估计失血量为208±264毫升。1例患者(4%)因胰腺周围严重粘连而需要转为开放远端胰腺切除术。整块切除LDP后的总体发病率为47%(n = 11),胰瘘发生率为39%(n = 9)。无30天或住院期间死亡病例。平均肿瘤大小为32±12毫米,平均收获的LN数量为19.8±9.3。最终组织学诊断无切缘阳性患者。1年、3年和5年总生存率分别为67%、49%和33%。
经验丰富的外科医生可安全应用整块切除LDP,其短期和长期结果令人满意,随着手术技术和技术创新的进步,支持LDP在腺癌中的进一步应用。